Skip to main content

Table 3 Candidate entities that can potentially be added to ChEBI concerning dementia and Alzheimer’s chemical interventions. adenotes mentions not contained in any previously mentioned chemical databases

From: Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics

triheptanoin

organosiloxanesa

bapineuzumab

semagacestat

solanezumab

tiapride

4-n-phenyl aminoquinolinea

tianeptine

benzoquinolizidinea

tramiprosate

remacemide

suloctidil

davunetide

remoxipride

rilapladib

ramelteon

cerebrolysin

praziquantel

chf5074

praxilene

idalopirdine

naftidrofuryl

fluspirilene

neramexane